Department of Chemistry, Faculty of Science, Zagazig University, Zagazig 44519, Egypt.
Department of Pharmaceutical Medicinal Chemistry, Faculty of Pharmacy, Horus University Egypt, New Damietta 34518, Egypt.
Int J Mol Sci. 2021 Sep 27;22(19):10396. doi: 10.3390/ijms221910396.
Novel candidates of 3-(4-(thiophen-2-yl)-pyridin/pyran/pyrimidin/pyrazol-2-yl)-1-indole derivatives (-) were designed by pairing the pyridine/pyrane/pyrimidine/pyrazole heterocycles with indole and thiophene to investigate their potential activities as (2,2'-azinobis (3-ethylbenzothiazoline-6-sulfonic acid) inhibitors. The purpose of these derivatives' modification is to create high-efficiency antioxidants, especially against ABTS, as a result of the efficiency of this set of key heterocycles in the inhibition of ROS. Herein, 2D QSAR modeling was performed to recommend the most promising members for further in vitro investigations. Furthermore, the pharmacological assay for antioxidant activity evaluation of the yielded indole-based heterocycles was tested against ABTS (2,2'-azinobis (3-ethylbenzothiazoline-6-sulfonic acid); by utilizing ascorbic acid as the standard. Candidate 10 showed higher antioxidant activity (IC = 28.23 μg/mL) than ascorbic acid itself which achieved (IC = 30.03 μg/mL). Moreover, molecular docking studies were performed for the newly designed and synthesized drug candidates to propose their mechanism of action as promising cytochrome peroxidase inhibitors compared to ascorbic acid as a reference standard. Our findings could be promising in the medicinal chemistry scope for further optimization of the newly designed and synthesized compounds regarding the introduced structure-activity relationship study (SAR) in order to get a superior antioxidant lead compound in the near future.
新型 3-(4-(噻吩-2-基)-吡啶/吡喃/嘧啶/吡唑-2-基)-1-吲哚衍生物(-)被设计为将吡啶/吡喃/嘧啶/吡唑杂环与吲哚和噻吩结合,以研究它们作为(2,2'-联氮双(3-乙基苯并噻唑啉-6-磺酸)抑制剂的潜在活性。这些衍生物的修饰目的是创造高效抗氧化剂,特别是针对 ABTS,这是由于这组关键杂环在抑制 ROS 方面的效率。在此,进行了 2D QSAR 建模,以推荐最有前途的成员进行进一步的体外研究。此外,通过利用抗坏血酸作为标准,对所产生的基于吲哚的杂环的抗氧化活性评估进行了药理学测定,以评估对 ABTS(2,2'-联氮双(3-乙基苯并噻唑啉-6-磺酸)的抗氧化活性。候选化合物 10 表现出比抗坏血酸(IC = 30.03 μg/mL)更高的抗氧化活性(IC = 28.23 μg/mL)。此外,还对新设计和合成的候选药物进行了分子对接研究,以提出它们作为潜在细胞色素过氧化物酶抑制剂的作用机制,与抗坏血酸作为参考标准相比。我们的研究结果在药物化学领域具有广阔的前景,可以进一步优化新设计和合成化合物,根据引入的构效关系研究(SAR),以在不久的将来获得更优越的抗氧化先导化合物。